APP Involvement in Monitoring ARIA in Alzheimer Disease

Panelists discuss how advanced practice providers (APPs) play a central role in identifying and managing amyloid-related imaging abnormalities (ARIA) that can occur with anti-amyloid therapy. Close monitoring through MRI and patient education are emphasized as best practices.

Panelists discuss how structured protocols help detect ARIA early and ensure prompt clinical response. APPs interpret results, communicate with supervising physicians, and adjust therapy as needed to maintain patient safety.

Panelists discuss how their vigilance and accessibility to patients enhance adherence and confidence in therapy, reinforcing the collaborative nature of Alzheimer care.